CDPH Warns Californians About the Dangers of Xylazine In response to the increase of xylazine in the illegal drug supply in the U.S., the California Department of Public Health (CDPH) has issued a letter to healthcare facilities and providers outlining the risks and warning signs of exposure, as well as patient care recommendations. Click HERE for the full article link. On April 12, 2023, the Biden-Harris Administration designated fentanyl adulterated or associated with xylazine as an emerging threat to the U.S. Xylazine is an FDA approved veterinary sedative but is not approved for use in humans. Xylazine can be found ... December 18, 2023 Drug Prescribing/Dispensing, Public Health 0 0 Comment Read More »
